Equity
€3.7m ▲ 23.1%
BioLizard has made a profit without a break since 2020.
BioLizard
Lifetime
7 annual accounts with figures on one time axispeak €3.9m (2025)
€3.9m▲ 3.8%
lowest -€242,224 (2019)
€324,234▲ 42.8%
peak €3.7m (2025)
€3.7m▲ 23.1%
€1.5m▲ 25.6%
peak 34.2 FTE (2025)
34.2 FTE▲ 3.3%
Board6 names since 2018
2 directorsNOVALIS GENERAL PARTNERS and 1 other
Owners
consolidatesNovalis
Documentsfilings and deeds
03-07-202628 days before the deadline
2025financial year
Result from €227,065 to €324,234Equity from €3.0m to €3.7mDebts from €1.2m to €1.5mInvestments €723,250
Key points
from the 2025 annual accountsResult
€324,234 ▲ 42.8%
The result rose in 2025 from €227,065 to €324,234.
Investments
€406,566 1.6 × depreciation
Green is investment, beige is depreciation.
Staff
37 employees on 31-12-2025
In 2025, 13 people joined and 9 left.
Filings
7 annual accounts since 2019
The last five annual accounts were filed 9 to 34 days before the end of the period.
At the same address
16 companies
Checked score
95
Excellent
Financially stronger than 61% of small companies in research and development (NACE 72)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 164 companies (NACE 72, small).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%lowest value
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: 0.1%▲ +0.1 percentage points vs 06-2025
08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: 0.1%▲ +0.1 percentage points vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026highest value
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026
10-2026: 0.1%● unchanged vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
1 change of registered office in 24 months
lowers risk
Liquidity: current ratio 3.67, cash €827,397
Size: 34.2 FTE, total assets €5.3m
Sector: Scientific research and development (NACE 72)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, small). It does better than 66% of them on solvency, 59% on liquidity, 48% on profitability and 71% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 6,782 companies had the same profile as BioLizard has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
That fits the bankruptcy probability of BioLizard itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,782 companies, not a prediction for BioLizard. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €340,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.67 (3.78 in 2024), above the usual 1.5. Short-term debt is 21.4% and cash 15.7% of total assets. 30.1% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
28 days early
2024
29 days early
2023
9 days early
2022
27 days early
2021
34 days early
2020
8 days early
2019
23 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 23 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
NG
NOVALIS GENERAL PARTNERS
Director, since 26-11-2019
EC
Effra Consult Ltd
Director, Caroline Vanovermeire
Shares in 2 companies, Biolizard and Digital Health Hub Biopole
Board & ownershipRecent changes
Registered office moved within Ghent
New registered office: Foreestelaan 88 Bus 201, 9000 Gent · Previous registered office: Ottergemsesteenweg-Zuid 808 bus B511, 9000 Gent · Permanent representative: Vandenberghe Sander · General meeting of 25-02-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0713914951
1 director appointed, 1 resignation
Resignation: Noromid VOF · Permanent representatives: Gerben Menschaert, Caroline Vanovermeire and Liesbeth Ceelen · Appointment: Effra Consult Ltd · Gazette deed
Appointment: Ceelen Consultancy CommV (persoon belast met het dagelijks bestuur,genaamd chief executive officer ofwel ceo)
Permanent representative: Liesbeth Ceelen · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BioLizard Ghent | €5.3m | €3.9m | 69.9% | 34.2 |
| CLOUDS OF CARE Ghent | €5.2m | €2.2m | 60.1% | 31.6 |
| Eastman Chemical Technology Ghent | €5.2m | €6.9m | 11.8% | 50.2 |
| SENSY Charleroi | €3.8m | €2.6m | 24.3% | 38.3 |
| EUROPEAN HEAT PUMP ASSOCIATION Brussels | €4.3m | €2.3m | 15.3% | 34.5 |
| BYTEFLIES Antwerp | €7.8m | €3.1m | -15.3% | 24.6 |
| EURO-MULTITEL Mons | €5.0m | €3.0m | 23.8% | 20.2 |
These companies have the same main activity as BioLizard: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €3.8m and €7.8m, founded between 2014 and 2019.
Official details
Source: KBO- Status
- Active since 26-11-2018Normal situation
- Registered office
- 17 active companies are registered at this address4 started in the 12 months before. Source: KBO register, as of 9 November 2026.
- Activity
- Other research and development on natural sciencesNACE 72109and 3 others
- Establishment unit
- 2.285.071.2639000 Ghent, since 26-11-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 02-10-2025
Annual accounts 2025
- ≈ €6.7mestimated
- €5.3m▲ 22.4%
- Employeeson 31-12-2025
- 37▲ 12.1%
- Filing
- Filed on 03-07-2026, 28 days before the end of the filing period
Insights on BioLizard
BioLizard has existed since 2018. In 2021 the gross margin rose from €424,738 to €1.2m and staff from 4.4 to 10.6 full-time equivalents.
Novalis holds 93% of the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BioLizard
- What is the company number of BioLizard?
- The company number of BioLizard is 0713.914.951. The VAT number is the same number with BE in front: BE 0713.914.951.
- Where is BioLizard based?
- The registered office is at Foreestelaan 88, 9000 Ghent.Company details
- What does BioLizard do?
- According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
- What is the legal form of BioLizard?
- BioLizard is a public limited company (NV).
- When was BioLizard founded?
- BioLizard was founded on 26-11-2018.
- Is BioLizard still active?
- Yes, BioLizard is an active enterprise in the KBO register.
- How many employees does BioLizard have?
- BioLizard had an average of 34.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of BioLizard?
- The turnover in financial year 2025 is ≈ €6.7m. This figure is estimated from the gross margin of €3.9m and 1,585 comparable companies of the same size. It probably lies between €4.6m and €11.0m. It is a rough estimate.
- Is BioLizard profitable?
- In financial year 2025, BioLizard made a profit of €324,234.
- Where can I find the annual accounts of BioLizard?
- BioLizard filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BioLizard due?
- BioLizard must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.